SITE007-0170

SITE007 (JPN) › SITE007-0170

SITE007-0170

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE007 (JPN) · Dr. Dubois
consented 2026-03-24

enrolled

AEs

4

Serious

1

Dropout signal

–

Adverse events

4

Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-02-08 (study day 132); relationship: not assessed

mild assessed

Grade 3 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-11-10 (study day 42); relationship: NOT RELATED; serious criteria: hospitalization

severe serious assessed

Grade 3 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-10-29 (study day 30); relationship: not assessed

severe assessed

Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-10-25 (study day 26); relationship: not assessed

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.